AJP - Heart AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 283: H1740-H1742, 2002; doi:10.1152/ajpheart.00442.2002
0363-6135/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (66)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwanke, U.
Right arrow Articles by Heusch, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwanke, U.
Right arrow Articles by Heusch, G.
Vol. 283, Issue 4, H1740-H1742, October 2002

REPORT
No ischemic preconditioning in heterozygous connexin43-deficient mice

Uwe Schwanke, Ina Konietzka, Alexej Duschin, Xiaokui Li, Rainer Schulz, and Gerd Heusch

Institute of Pathophysiology, University of Essen Medical School, 45122 Essen, Germany


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Protein kinase Cepsilon (PKCepsilon ) plays a central role in ischemic preconditioning (IP) in mice and rabbits, and activated PKCepsilon colocalizes with and phosphorylates connexin43 (Cx43) in rats and humans. Whether or not Cx43 contributes to the mechanism(s) of IP in vivo is yet unknown. Therefore, wild-type (n = 8) and heterozygous Cx43-deficient mice (n = 8) were subjected to 30 min occlusion and 120 min reperfusion of the left anterior descending coronary artery. IP was induced by one cycle of 5 min occlusion and 10 min reperfusion (n = 8/8 mice) before the sustained occlusion. Infarct size was reduced by IP in wild-type mice [11.3 ± 3.4% vs. 23.7 ± 7.2% of the left ventricle (LV), P < 0.05] but not in Cx43-deficient mice (26.0 ± 6.0% vs. 25.1 ± 3.8% of LV). Also, three cycles of 5 min occlusion and 10 min reperfusion (n = 5) did not induce protection in Cx43-deficient mice (27.6 ± 5.5 % of LV). Thus Cx43 contributes to the protection of IP in mice in vivo.

mouse heart in situ; infarct size; gap junctions


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

ISCHEMIC PRECONDITIONING (IP) by brief episodes of ischemia-reperfusion protects the myocardium from the damage induced by a subsequent more prolonged ischemia. Several triggers and mediators of IP have been identified, whereas the final end effector is still unknown (15). Protein kinase Cepsilon (PKCepsilon ) is an established mediator of IP in mice and rabbits, whereas other PKC isoforms may be more important in other species (15). PKCepsilon is involved in signaling complexes with at least 36 proteins (1, 9, 18), among them connexin43 (Cx43) (10), an integral protein of myocardial gap junctions. Activated PKCepsilon colocalizes with Cx43 and contributes to phosphorylation of Cx43 in rats (3) and humans (2), which might then modulate gap junction transmission characteristics and intercellular communication. Indeed, in isolated mouse hearts, uncoupling of gap junctions using heptanol abolished infarct size reduction by IP (8). The data on the effect of gap junction uncoupling on infarct size per se are controversial. Pretreatment with the gap junction uncoupler heptanol had no effect on infarct size in isolated rabbit hearts (6), but heptanol given during early ischemia decreased infarct size in isolated rabbit hearts (16). Also, in pigs in vivo heptanol given during early reperfusion decreased infarct size (4). Data on the importance of Cx43 for IP in vivo, however, are lacking. We therefore studied whether or not Cx43 is involved in the cardioprotection by IP using heterozygous Cx43-deficient mice.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The experimental protocols were approved by the bioethics committee of the district of Düsseldorf, Germany. Mice were handled according to the guidelines of the American Physiological Society.

We used the in situ mouse heart model developed by Guo et al. (5). Briefly, male and female C57BL/6J wild-type and heterozygous Cx43-deficient mice (B6.129-Gja1tm1Kdr, JAX mice; Bar Harbor, ME) (12) (weight: 30.5 ± 4.5 g, age: 14-20 wk) were anesthetized with pentobarbital sodium (80 mg/kg ip) and atropine sulfate (0.04 mg/kg ip). Electrocardiogram and rectal temperature were monitored continuously. Temperature was held close to 37°C. After intubation (polyethlene-60 tubing) and with ventilation (oxygen-supplemented room air, 105 breaths/min ZOOVENT Jetsys, Universal Lung Ventilators; Netherfield, UK), a midline thoracotomy and pericardiotomy were performed. With the use of a 9.0-nylon suture, a nontraumatic balloon occluder was attached to the left anterior descending coronary artery 1 mm distal to the tip of the left auricle. Control mice (n = 8/8) underwent 30 min occlusion and 120 min reperfusion. IP was induced by 5 min occlusion and 10 min reperfusion before the sustained occlusion (1×IP, n = 8/8). Five additional Cx43-deficient mice were subjected to three cycles of 5 min occlusion and 10 min reperfusion (3×IP). At the end of the protocol, mice were heparinized, and the hearts were rapidly excised and immersed into ice-cold saline (~4°C). The aorta was cannulated and perfused with Krebs-Henseleit solution, 1% 2,3,5-triphenyltetrazolium chloride, and 10% KCl. Hearts were cut into four to five transverse slices, and infarct size was measured by planimetry and expressed as a percentage of the left ventricle (8).

For Western immunoblotting of Cx43, a primary rabbit anti-Cx43 (Zymed; San Francisco, CA) and secondary anti-rabbit IgG horseradish peroxidase-conjugated antibody (Cell Signaling; Beverly, MA) were used. Analysis of the amount of Cx43 was performed in right ventricular tissue (14.4 ± 5.3 mg) by enhanced chemiluminescence and quantitative two-dimensional densitometry (wild-type/Cx43+/-, n = 4/3 mice).

Data are means ± SD. Data analysis was performed with Sigma Stat software (Jandel Scientific; San Rafael, CA) by one-way ANOVA. A P value <0.05 was taken to indicate statistical significance.


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Heart rate and temperature were not different among the five groups throughout the protocol (Table 1). The heterozygous Cx43-deficient mice had 55.5 ± 9.3% of wild-type right ventricular Cx43 expression (Fig. 1). Infarct size was reduced by IP in wild-type mice but not in heterozygous Cx43-deficient mice, not even when subjected to three IP cycles (Fig. 2).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Heart rate and temperature of 5 groups throughout the protocol



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 1.   Typical autoradiograph of right ventricular connexin43 (Cx43) in a wild-type (WT) and a heterozygous Cx43-deficient mouse (Cx43+/-) (A) and densitometry data of Cx43 protein in wild-type and Cx43-deficient right ventricular tissue (B; means ± SD, *P < 0.05 vs. WT). AU, arbitrary units.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Individual infarct size data and corresponding means ± SD, *P < 0.05 vs. other groups. Open circles, males; closed circles, females. CON, 30-min occlusion, 120-min reperfusion, 1×IP/3×IP, one/three cycle(s) of 5-min occlusion, 10-min reperfusion before the sustained occlusion; LV, left ventricle.

Heterozygous Cx43-deficient mice have the same phenotype as wild-type mice (7). In the present study, heart rate was comparable between groups, and Cx43-deficient mice also had no electrocardiogram abnormalities. In the present study, 30-min occlusion and 120-min reperfusion resulted in similar infarct sizes in both genotypes. Thus Cx43 deficiency per se does not exaggerate tissue damage under sustained ischemia. In contrast, the infarct-sparing effect of IP was completely abolished in heterozygous Cx43-deficient mice. Apparently 50% of Cx43 is not sufficient to sustain the mechanism(s) of IP.

Our findings are somewhat contrary to prior findings in rat brain cells exposed to ischemia, which close their gap junctions to isolate themselves from surrounding cells (11). If this were true for cardiomyocytes, Cx43 deficiency in our study should have been cardioprotective. There is, however, good evidence that gap junctions are open at some time point during myocardial ischemia. In isolated rat cardiomyocytes and hearts, open gap junctions permit the equilibration of cytosolic concentrations of Na+ and Ca2+, thus contributing to propagation of rigor contracture (13, 14). In isolated mouse hearts, uncoupling of gap junctions using heptanol abolished IP protection, suggesting that an as-yet-unknown "survival" factor may be transmitted via gap junctions during IP (8). Also in the present study in vivo, to the extent that gap junctions remained open, the lack of IP in heterozygous Cx43-deficient mice points to the importance of intercellular communication (17) in the mechanism(s) of IP.

A number of recent investigations revealed that activated PKCepsilon forms signaling complexes with other proteins, which can be categorized as structural proteins, signaling proteins (Cx43 among them), and stress-activated proteins (10). The composition of such complexes is dynamically altered and causally involved in cardioprotective signaling (10, 19). The recruitment of Cx43 to the PKCepsilon signaling complex is associated with posttranslational modification of Cx43 during cardioprotection (10). Alternatively, disruption of the PKCepsilon -Cx43 signaling complex could act to prevent phosphorylation of some other unidentified targets associated with the complex. Obviously, a 50% reduction of functioning PKCepsilon -Cx43 signaling complexes is sufficient to completely abolish the infarct-sparing effect by IP. We propose Cx43 might be involved in cellular volume regulation, which is considered as one potential end effector of IP (15).


    FOOTNOTES

Address for reprint requests and other correspondence: G. Heusch, Institut für Pathophysiologie, Universitätsklinikum Essen, Hufelandstraße 55, 45122 Essen, Germany (E-mail: gerd.heusch{at}uni-essen.de).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

10.1152/ajpheart.00442.2002

Received 23 May 2002; accepted in final form 25 June 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1.   Baines, CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, and Ping P. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart. Circ Res 90: 390-397, 2002[Abstract/Free Full Text].

2.   Bowling, N, Huang X, Sandusky GE, Fouts RL, Mintze K, Esterman M, Allen PD, Maddi R, McCall E, and Vlahos CJ. Protein kinase C-alpha and -epsilon modulate connexin-43 phosphorylation in human heart. J Mol Cell Cardiol 33: 789-798, 2001[Web of Science][Medline].

3.   Doble, BW, Ping P, and Kardami E. The epsilon  subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 86: 293-301, 2000[Abstract/Free Full Text].

4.   Garcia-Dorado, D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, Barrabés JA, and Soler-Soler J. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 96: 3579-3586, 1997[Abstract/Free Full Text].

5.   Guo, Y, Wu WJ, Qiu Y, Tang XL, Yang Z, and Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 275: H1375-H1387, 1998[Abstract/Free Full Text].

6.   Gysembergh, A, Kloner RA, and Przyklenk K. Pretreatment with the gap junction uncoupler heptanol does not limit infarct size in rabbit heart. Cardiovasc Pathol 10: 13-17, 2001[Web of Science][Medline].

7.   Kirchhoff, S, Kim JS, Hagendorff A, Thönissen E, Krüger O, Lamers WH, and Willecke K. Abnormal cardiac conduction and morphogenesis in connexin40 and connexin43 double-deficient mice. Circ Res 87: 399-405, 2000[Abstract/Free Full Text].

8.   Li, G, Whittaker P, Yao M, Kloner RA, and Przyklenk K. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol 11: 158-165, 2002[Web of Science][Medline].

9.   Ping, P, Song C, Zhang J, Guo Y, Cao X, Li RCX, Wu W, Vondriska TM, Pass JM, Tang XL, Pierce WM, and Bolli R. Formation of protein kinase Cepsilon -Lck signaling modules confers cardioprotection. J Clin Invest 109: 499-507, 2002[Web of Science][Medline].

10.   Ping, P, Zhang J, Pierce WM, and Bolli R. Functional proteomic analysis of protein kinase C epsilon  signaling complexes in the normal heart and during cardioprotection. Circ Res 88: 59-62, 2001[Abstract/Free Full Text].

11.   Rawanduzy, A, Hansen A, Hansen TW, and Nedergaard M. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J Neurosurg 87: 916-920, 1997[Web of Science][Medline].

12.   Reaume, AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Jeneja SC, Kidder GM, and Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science 267: 1831-1834, 1995[Abstract/Free Full Text].

13.   Ruiz-Meana, M, Garcia-Dorado D, Hofstaetter B, Piper HM, and Soler-Soler J. Propagation of cardiomyocyte hypercontracture by passage of Na+ through gap junctions. Circ Res 85: 280-287, 1999[Abstract/Free Full Text].

14.   Ruiz-Meana, M, Garcia-Dorado D, Lane S, Pina P, Inserte J, Mirabet M, and Soler-Soler J. Persistence of gap junction communication during myocardial ischemia. Am J Physiol Heart Circ Physiol 280: H2563-H2571, 2001[Abstract/Free Full Text].

15.   Schulz, R, Cohen MV, Behrends M, Downey JM, and Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res 52: 181-198, 2001[Free Full Text].

16.   Tanno, M, Tsuchida A, Nishino Y, Matsumoto T, Genda S, Sakamoto J, and Miura T. Blockade of gap junction communication during the early period of ischemia protects cardiomyocytes from infarction (Abstract). Circulation 104: II-43, 2001.

17.   van Veen, TAB, van Rijen HVM, and Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 51: 217-229, 2001[Abstract/Free Full Text].

18.   Vondriska, TM, Klein JB, and Ping P. Use of functional proteomics to investigate PKCepsilon -mediated cardioprotection: the signaling module hypothesis. Am J Physiol Heart Circ Physiol 280: H1434-H1441, 2001[Abstract/Free Full Text].

19.   Vondriska, TM, Zhang J, Song C, Tang XL, Cao X, Baines CP, Pass JM, Wang S, Bolli R, and Ping P. Protein kinase C epsilon -Src modules direct signal transduction in nitric oxide-induced cardioprotection. Complex formation as a means for cardioprotective signaling. Circ Res 88: 1306-1313, 2001[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 283(4):H1740-H1742
0363-6135/02 $5.00 Copyright © 2002 the American Physiological Society



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. Ruiz-Meana, A. Rodriguez-Sinovas, A. Cabestrero, K. Boengler, G. Heusch, and D. Garcia-Dorado
Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia reperfusion injury
Cardiovasc Res, January 5, 2008; (2008) cvm062v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Boengler, I. Konietzka, A. Buechert, Y. Heinen, D. Garcia-Dorado, G. Heusch, and R. Schulz
Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1764 - H1769.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Eckle, A. Grenz, D. Kohler, A. Redel, M. Falk, B. Rolauffs, H. Osswald, F. Kehl, and H. K. Eltzschig
Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2533 - H2540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Przyklenk, M. Maynard, and P. Whittaker
First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H2008 - H2012.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Mullick, Z. Leon, G. Min-Oo, J. Berghout, R. Lo, E. Daniels, and P. Gros
Cardiac Failure in C5-Deficient A/J Mice after Candida albicans Infection.
Infect. Immun., August 1, 2006; 74(8): 4439 - 4451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Vetterlein, C. Muhlfeld, C. Cetegen, R. Volkmann, C. Schrader, and G. Hellige
Redistribution of connexin43 in regional acute ischemic myocardium: influence of ischemic preconditioning
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H813 - H819.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler
Protective effect of gap junction uncouplers given during hypoxia against reoxygenation injury in isolated rat hearts
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H648 - H656.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Miura, Y. Ohnuma, A. Kuno, M. Tanno, Y. Ichikawa, Y. Nakamura, T. Yano, T. Miki, J. Sakamoto, and K. Shimamoto
Protective role of gap junctions in preconditioning against myocardial infarction
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H214 - H221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Padilla, D. Garcia-Dorado, A. Rodriguez-Sinovas, M. Ruiz-Meana, J. Inserte, and J. Soler-Soler
Protection afforded by ischemic preconditioning is not mediated by effects on cell-to-cell electrical coupling during myocardial ischemia-reperfusion
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1909 - H1916.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. M. YELLON and J. M. DOWNEY
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Physiol Rev, October 1, 2003; 83(4): 1113 - 1151.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (66)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwanke, U.
Right arrow Articles by Heusch, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwanke, U.
Right arrow Articles by Heusch, G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online